MGRX
Income statement / Annual
Last year (2023), Mangoceuticals, Inc.'s total revenue was $731,493.00,
an increase of 8,083.16% from the previous year.
In 2023, Mangoceuticals, Inc.'s net income was -$9.21 M.
See Mangoceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$731,493.00 |
$8,939.00 |
$0.00 |
Cost of Revenue |
$299,992.00
|
$4,089.00
|
$0.00
|
Gross Profit |
$431,501.00
|
$4,850.00
|
$0.00
|
Gross Profit Ratio |
0.59
|
0.54
|
0
|
Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$6.45 M
|
$2.00 M
|
$70,080.00
|
Selling & Marketing Expenses |
$2.10 M
|
$352,860.00
|
-$52,560.00
|
Selling, General & Administrative Expenses |
$8.55 M
|
$2.00 M
|
$17,520.00
|
Other Expenses |
$1.10 M
|
$0.00
|
$0.00
|
Operating Expenses |
$9.65 M
|
$2.00 M
|
$17,520.00
|
Cost And Expenses |
$9.95 M
|
$2.00 M
|
$17,520.00
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$0.00
|
$6,473.00
|
$181.00
|
Depreciation & Amortization |
$24,889.00
|
$3,863.00
|
$70,080.00
|
EBITDA |
-$9.19 M |
-$1.99 M |
$52,560.00 |
EBITDA Ratio |
-12.56
|
-222.36
|
0
|
Operating Income Ratio |
-12.6
|
-222.8
|
0
|
Total Other Income/Expenses Net |
$6,473.00
|
-$6,473.00
|
-$53,284.00
|
Income Before Tax |
-$9.21 M
|
-$2.00 M
|
-$17,701.00
|
Income Before Tax Ratio |
-12.59
|
-223.52
|
0
|
Income Tax Expense |
$0.00
|
-$224,622.00
|
-$70,080.00
|
Net Income |
-$9.21 M
|
-$2.00 M
|
-$17,701.00
|
Net Income Ratio |
-12.59
|
-223.52
|
0
|
EPS |
-6.45 |
-0.12 |
-0.001 |
EPS Diluted |
-6.45 |
-0.12 |
-0.001 |
Weighted Average Shares Out |
$1.43 M
|
$17.32 M
|
$17.32 M
|
Weighted Average Shares Out Diluted |
$1.43 M
|
$17.32 M
|
$17.32 M
|
Link |
|
|
|